Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
What Is Squamous Cell Lung Cancer and How Does It Differ from Other Types?
What Is Squamous Cell Lung Cancer and How Does It Differ from Other Types? 3

At Liv Hospital, we know how vital it is to understand squamous cell lung cancer. It’s a big part of non-small cell lung cancer (NSCLC). This cancer type makes up about 25-30% of lung cancer cases. It’s also closely linked to smoking.

Studies have found that lung cancer is the most common and deadly cancer globally. NSCLC makes up about 85% of all lung cancer cases. We aim to offer top-notch, patient-focused care. This helps people deal with their diagnosis better. For more on treatment, check out our page on lung cancer treatment.

Key Takeaways

  • Squamous cell lung cancer is a significant subtype of NSCLC.
  • It is strongly associated with smoking.
  • NSCLC accounts for approximately 85% of all lung cancer cases.
  • Understanding the type of lung cancer is key for effective treatment.
  • Liv Hospital provides advanced, patient-centric care for lung cancer patients.

Understanding Squamous Cell Lung Cancer

A detailed microscopic view of squamous cell lung cancer, showcasing the irregular, overlapping layers of atypical squamous epithelial cells. The image is sharp and in-focus, with a clean white background that highlights the intricate cellular structures. Subtle variations in texture, size, and shape of the cancerous cells are visible, conveying the aggressive and disorganized nature of this lung cancer subtype. The lighting is soft and diffused, creating depth and dimension within the cellular arrangement. The angle is slightly tilted, providing a dynamic perspective that invites the viewer to closely examine the underlying pathology of this devastating disease.
What Is Squamous Cell Lung Cancer and How Does It Differ from Other Types? 4

Squamous cell lung cancer is the second most common lung cancer type. It has its own challenges in diagnosis and treatment. We will explore its definition, classification, and who is most affected by it.

Definition and Classification

Squamous cell lung cancer comes from squamous cells in the airways. It is aggressive and often linked to smoking. Understanding its histological features helps distinguish it from other lung cancers.

Squamous cell lung carcinoma is classified by its differentiation level. This level ranges from well-differentiated to poorly differentiated. Knowing this helps predict outcomes and guide treatments.

Prevalence and Demographics

Squamous cell lung cancer is a big part of lung cancer cases globally. It hits men more often and is linked to smoking. Older adults and those who have smoked are most at risk.

Studies show it’s key to know who gets squamous cell lung cancer. This helps in making public health plans and finding cancer early.

Historical Context and Research Evolution

Our understanding of squamous cell lung cancer has grown a lot. Genomics and molecular biology have been key. Early research has helped shape today’s treatments, and ongoing studies keep bringing new discoveries.

Recent clinical trials have shown the power of genomics in lung cancer treatment. These findings have led to more personalized care and better patient results.

The Biology of Squamous Cell Lung Carcinoma

image 4980 LIV Hospital
What Is Squamous Cell Lung Cancer and How Does It Differ from Other Types? 5

Squamous cell lung carcinoma is a complex disease. It involves many cellular and molecular processes. These processes are different from other lung cancers. We will look into these to understand the disease better.

Cell Origin and Development

This type of lung cancer starts from squamous cells. These cells line the airways and protect the lungs. It often develops due to chronic irritation, like from smoking.

The change from normal cells to cancer involves genetic and epigenetic changes. Knowing these changes helps find new treatments.

Molecular Characteristics

Squamous cell lung carcinoma has unique molecular features. It has genetic mutations and changes in signaling pathways. For example, TP53 mutations are common and play a big role in tumor growth.

It also has proteins that help cells grow and survive. These traits help in diagnosing and treating the disease.

Central vs. Peripheral Tumors

Squamous cell lung carcinoma can be central or peripheral. Central tumors are in the larger airways and are more common. Peripheral tumors are in smaller airways and are less common.

The tumor’s location affects symptoms and treatment. Central tumors can cause coughing and bleeding because they are close to major airways.

Genetic Mutations and Pathways

Genetic mutations and pathway changes are key in squamous cell lung carcinoma. The PI3K/AKT and MAPK/ERK pathways are involved. They control cell growth and survival.

Understanding these genetic changes is vital for creating targeted treatments. It helps improve patient outcomes.

Genetic MutationFrequency in Squamous Cell Lung CarcinomaImplication
TP53HighTumor suppressor gene; mutations lead to loss of function
PIK3CAModerateInvolved in PI3K/AKT pathway; mutations lead to increased cell proliferation
KRASLowInvolved in MAPK/ERK pathway; mutations lead to increased cell proliferation

Risk Factors for Developing Squamous Cell Cancer of the Lung

Risk factors are key in the start of squamous cell lung cancer, affecting millions. Knowing these factors helps in prevention, early detection, and managing the disease.

Smoking and Tobacco Use

Smoking is the biggest risk for squamous cell carcinoma of the lungs. Tobacco smoke has many harmful substances that can harm lung cells, leading to cancer. Quitting smoking is a big step in lowering the risk of squamous cell lung cancer.

Research shows smoking causes 80-90% of lung cancer deaths. The risk grows with how long and how much you smoke. For example, heavy smokers face a 20-fold higher risk of lung cancer than non-smokers.

Environmental and Occupational Exposures

Being exposed to certain harmful substances increases the risk of non small cell squamous cancer. These include:

  • Radon gas
  • Asbestos
  • Arsenic
  • Certain chemicals in construction, mining, and manufacturing

Asbestos exposure, for instance, can lead to lung cancer, mainly in those who worked with it. People exposed to carcinogens at work should get regular lung cancer screenings.

Genetic Predisposition

Genetics also play a part in squamous cell cancer in lungs. Those with a family history of lung cancer are at higher risk. Certain genetic mutations, like in the TP53 gene, increase the risk of squamous cell lung cancer.

“Genetic predisposition is an important factor in lung cancer, and understanding one’s genetic risk can help in early detection and prevention.”

– Dr. Lung Cancer Specialist

Other Contributing Factors

Other factors that may raise the risk of squamous cell carcinoma lung cancer include:

  1. Age: Most cases are in people over 65.
  2. Previous lung diseases: Conditions like COPD can increase the risk.
  3. Diet and lifestyle: A diet low in fruits and vegetables and high in processed foods may contribute to the risk.

For more information on lung cancer and its risk factors, visit Liv Hospital’s lung cancer resource page.

Comparing Squamous Cell Lung Cancer to Other Lung Cancer Types

It’s key to know how squamous cell lung cancer differs from other types. Studies show squamous cell carcinoma has unique traits. These are different from adenocarcinoma and small cell lung cancer.

Differences Between Squamous Cell and Adenocarcinoma

Squamous cell lung cancer and adenocarcinoma are both non-small cell lung cancer. But they have different molecular traits and grow in different ways. Squamous cell carcinoma is often more aggressive, with bigger tumors and a higher chance of spreading.

Non-Small Cell vs. Small Cell Lung Cancer

It’s important to tell non-small cell lung cancer (like squamous cell and adenocarcinoma) apart from small cell lung cancer. They need different treatments and have different outlooks. Non small cell squamous carcinoma grows more slowly than small cell lung cancer.

When diagnosing squamous cell ca lung, knowing these differences is vital. It helps choose the best treatment. We focus on accurate diagnosis and personalized treatment plans for lung cancer.

What is squamous cell lung cancer?

Squamous cell lung cancer is a type of lung cancer. It starts in the squamous cells. These cells line the airways in the lungs.

Is squamous cell lung cancer related to smoking?

Yes, it is strongly linked to smoking. Smoking is the main cause of this lung cancer type.

What are the symptoms of squamous cell lung cancer?

Symptoms include coughing, chest pain, and trouble breathing. Coughing up blood is also common. Symptoms depend on the tumor’s size and location.

How is squamous cell lung cancer diagnosed?

Diagnosis starts with imaging tests like CT scans. Then, a biopsy is done to check for cancer cells.

What are the risk factors for developing squamous cell lung cancer?

Risk factors include smoking and exposure to harmful substances. Asbestos and radon are examples. Genetic predisposition also plays a role.

How does squamous cell lung cancer differ from other types of lung cancer?

It’s a non-small cell lung cancer with unique features. It differs from adenocarcinoma and small cell lung cancer in growth and behavior.

What is the prevalence of squamous cell lung cancer?

It’s a common lung cancer type, mainly among smokers.

Can non-smokers develop squamous cell lung cancer?

Yes, non-smokers can get it too. This is less common but can happen due to environmental exposures.

What are the treatment options for squamous cell lung cancer?

Treatment depends on the cancer’s stage and location. It may include surgery, chemotherapy, or radiation therapy. Sometimes, a combination is used.

Reference

Lung Cancer Foundation of America (LCFA). Squamous Cell Carcinomas. https://lcfamerica.org/about-lung-cancer/diagnosis/types/squamous-cell-carcinomas/

NCBI. PMC article. https://pmc.ncbi.nlm.nih.gov/articles/PMC7385267/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91